Cumberland Pharmaceuticals (CPIX) Gross Profit (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Gross Profit across 17 years of filings, most recently posting $7.2 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $7.2 million, down 3.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.8 million (down 0.62% YoY), and the FY2025 annual result was $37.9 million, up 21.01% from the prior year.
• Gross Profit came in at $7.2 million for Q1 2026 at Cumberland Pharmaceuticals, down from $19.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $19.9 million in Q4 2025 to a low of -$1.1 million in Q4 2022.
• The 5-year median for Gross Profit is $7.5 million (2025), against an average of $7.8 million.
• Across the five-year window, Gross Profit slumped 121.32% in 2022 and jumped 831.78% in 2023, its largest moves.
• Cumberland Pharmaceuticals' Gross Profit stood at -$1.1 million in 2022, then surged by 831.78% to $7.8 million in 2023, then jumped by 112.83% to $16.7 million in 2024, then advanced by 19.52% to $19.9 million in 2025, then plunged by 63.83% to $7.2 million in 2026.
• The last three Gross Profit figures came in at $7.2 million (Q1 2026), $19.9 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.